The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)

In 2013 experts of The Russian Medical Society on Arterial Hypertension (RMSAH) had prepared recommendations about management of patients with arterial hypertension (AH) and metabolic disorders (such as obesity, carbohydrate and lipid metabolism, hyperuricemia) and which chapters about diagnosis and correction were expanded, compared to the previous RMSAH recommendations. We also added a chapter about management of patients with AH and type 2 diabetes (T2D). Treatment and diagnosis algorithms of metabolic syndrome (MS) and T2D, discussed in these recommendations, will help us early identify and correct these disorders and will reduce cardiovascular events in patients with AH, even mortality one.

Download Full-text

The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities

Systemic Hypertension ◽

10.26442/2075082x.2018.4.000028 ◽

2018 ◽

Vol 15 (4) ◽

pp. 8-16

Author(s):

O D Ostroumova ◽

A I Kochetkov

Keyword(s):

Arterial Hypertension ◽

Diagnosis And Treatment ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

European Guidelines ◽

Aortic Pathology ◽

Pressure Lowering ◽

Artery Disease ◽

Based Medicine

The review from the standpoint of the newest European guidelines for the diagnosis and treatment of arterial hypertension discusses the role of highly selective b-blockers and, above all, the superior member of these drugs - bisoprolol in blood pressure lowering therapy in comorbid patients with arterial hypertension. In terms of evidence-based medicine, the benefits of bisoprolol in patients with comorbid coronary heart disease, chronic heart failure, atrial fibrillation, and aortic pathology are discussed. The data on the feasibility and the possibility of including in the therapy highly selective b-adrenergic blockers in patients with chronic obstructive pulmonary disease, peripheral artery disease, diabetes and sexual dysfunction are presented

Download Full-text

Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19

Systemic Hypertension ◽

10.26442/2075082x.2020.3.200362 ◽

2020 ◽

Vol 17 (3) ◽

pp. 35-41

Author(s):

Irina E. Chazova ◽

Natalia V. Blinova ◽

Vera A. Nevzorova ◽

Juliya V. Zhernakova ◽

Mikhail P. Savenkov ◽

...

Keyword(s):

Arterial Hypertension ◽

Medical Society ◽

Target Cells ◽

The Novel ◽

Angiotensin Converting Enzyme 2 ◽

High Prevalence ◽

Coronavirus Infection ◽

Novel Coronavirus ◽

The Relationship ◽

Russian Medical

The novel coronavirus infection (COVID-19) caused by the b-coronavirus SARS-CoV-2, and leads to acute respiratory distress-syndrome, has affected more than nineteen million people worldwide, resulting in 0.7 million deaths as of August 2020. The fact that the virus uses angiotensin-converting enzyme 2 as a receptor for entering the target cell, and the high prevalence of hypertension and other cardiovascular diseases among patients with COVID-19, have caused serious discussions on the management of such patients. This consensus of experts from the Russian Medical Society for Arterial Hypertension analyzed the existing data on the relationship between COVID-19 and hypertension, the pathophysiological aspects of the penetration of the virus into target cells and the use of renin-angiotensin-aldosterone system inhibitors in patients with hypertension and COVID-19.

Download Full-text

Features of clinical-functional parameters of the heart, vessels and microcirculation in patients with arterial hypertension in the combination to chronic obstructive pulmonary diseases

Bulletin of Siberian Medicine ◽

10.20538/1682-0363-2010-6-80-86 ◽

2010 ◽

Vol 9 (6) ◽

pp. 80-86

Author(s):

I. S. Shpagin ◽

A. V. Shabalin ◽

L. A. Shpagina ◽

O. N. Gerasimenko ◽

N. V. Shlyakhtina

Keyword(s):

Blood Flow ◽

Arterial Hypertension ◽

Peripheral Blood ◽

Pulmonary Diseases ◽

Chronic Obstructive ◽

Peripheral Blood Flow ◽

Worst Case ◽

Flow Disturbances ◽

Chronic Obstructive Pulmonary Diseases ◽

Clinical And Functional Status

The clinical and functional status of the heart, peripheral vessels and microcirculation. The features of structural-functional state of the heart and peripheral vessels. Showing violations cardiohemodynamic and peripheral blood flow. Identified various pathological hemodynamic types. The worst-case remodeling and blood flow disturbances were detected in patients with arterial hypertension in combination to chronic obstructive diseases of lungs against pulmonary hypertensia.

Download Full-text

Hypertensic crisis — clinical interpretation of the term

Clinical Medicine (Russian Journal) ◽

10.30629/0023-2149-2021-99-2-146-149 ◽

2021 ◽

Vol 99 (2) ◽

pp. 146-149

Author(s):

E. V. Kryukov ◽

A. N. Fursov ◽

N. P. Potekhin ◽

S. A. Chernov ◽

E. G. Zakharova

Keyword(s):

Blood Pressure ◽

Clinical Practice ◽

Arterial Hypertension ◽

Clinical Status ◽

Cardiovascular Complications ◽

Medical Society ◽

Safe Level ◽

Russian Medical ◽

Rapid Relief ◽

Over Time

The term «hypertensic crisis» is used to describe a condition that develops over time, and the outcomes depend on both, timing and completeness of medical care and the initial clinical status of the patient. The term «uncontrollable arterial hypertension» in ESC and RSC recommendations (2018–2020) cannot replace the concept of “uncomplicated HC” completely . It is advisable to adhere to the recommendations of the Russian Medical Society for Arterial Hypertension (RMSAH) developed in 2019, in which the division into complicated and uncomplicated HC still remains. In clinical practice, three variants of a signifi cant increase in blood pressure in patients with arterial hypertension should be distinguished: an isolated increase in blood pressure, uncomplicated and complicated HC. It is necessary to stratify patients with uncomplicated HC according to the degree of risk of cardiovascular complications development in order to determine the indications for their hospitalization. The rapid relief of a significant increase in blood pressure should lead to a safe level of patient’s pressure, taking into account the risk of hypotension and hypoperfusion of vital organs and systems.

Download Full-text

Russian medical society on arterial hypertension (RMSAH) Consensus of Experts on the use of radiofrequency denervation of the renal arteries in patients with arterial hypertension

Systemic Hypertension ◽

10.26442/2075082x.2020.4.200398 ◽

2021 ◽

Vol 17 (4) ◽

pp. 7-18

Author(s):

Nikolai M. Danilov ◽

Regina A. Agaeva ◽

Yurii G. Matchin ◽

Vladimir A. Grigin ◽

Galina V. Shchelkova ◽

...

Keyword(s):

Clinical Trials ◽

Arterial Hypertension ◽

Randomized Clinical Trials ◽

Renal Arteries ◽

Medical Society ◽

Sustained Reduction ◽

Radiofrequency Denervation ◽

Clinically Significant ◽

Renal Artery Denervation ◽

Russian Medical

Hyperactivity of the sympathetic nervous system is one of the basic mechanisms in the development of arterial hypertension (AH). Transcatheter renal artery denervation is aimed to destroy the renal sympathetic afferent and efferent nerves to achieve a sustained reduction in blood pressure. Since 2017, all II generation studies have demonstrated that sympathetic denervation provides clinically significant BP reduction. Russian Medical Society for Arterial Hypertension (RMSAH) experts consider SD as a possible addition to the antihypertensive strategy in patients with uncontrolled AH and recommend denervation of the renal arteries in registers and clinical trials. On the basis of existing randomized clinical trials, as well as the experience of radiofrequency denervation in Russia, the experts of RMSAH present a consensus and view of the current situation in the field of renal denervation.

Download Full-text

Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction

Systemic Hypertension ◽

10.26442/2075082x.2021.2.200836 ◽

2021 ◽

Vol 18 (2) ◽

pp. 69-79

Author(s):

Tatiana A. Alekseeva ◽

Alexander Yu. Litvin ◽

Eugenia M. Elfimova ◽

Oxana O. Mikhailova ◽

Vera N. Larina ◽

...

Keyword(s):

Erectile Dysfunction ◽

Endothelial Dysfunction ◽

Sexual Health ◽

Arterial Hypertension ◽

Antihypertensive Drugs ◽

Clinical Manifestations ◽

Medical Society ◽

Sexual Dysfunctions ◽

Phosphodiesterase Type 5 Inhibitors ◽

Russian Medical

Sexual health is an essential part of overall health, and an active and healthy sex life is an important aspect of a good quality of life. Cardiovascular diseases and sexual health disorders have common risk factors (arterial hypertension, diabetes mellitus, dyslipidemia, obesity and smoking) and common pathogenesis (endothelial dysfunction, inflammation and atherosclerosis). All this led to speculations about the pathophysiology and treatment options for sexual dysfunctions. The use of phosphodiesterase type 5 inhibitors has revolutionized the treatment of erectile dysfunction (ED) in men. This article focuses on ED and its relationship with hypertension. This document was created by experts from the Russian Medical Society of Arterial Hypertension with the participation of a member of the European Society of Hypertension Working Group on Sexual Dysfunction and Arterial Hypertension. In recent years, the expert group was very active in educating hypertension specialists and related specialties physicians about ED via numerous lectures at national and international congresses. It has been noted that ED precedes the development of coronary heart disease. The artery diameter hypothesis has been proposed as a possible explanation for this observation. Clinical manifestations of atherosclerotic lesions and/or endothelial dysfunction of the penile arteries may precede those in larger arteries. Patients with hypertension who receive antihypertensive drugs are more likely to suffer from sexual dysfunctions compared to untreated patients. The occurrence of ED appears to be related to the undesirable effects of antihypertensive drugs on the penile tissues. There is information about various effects of antihypertensive drugs on erectile function.

Download Full-text

Phenotype of chronic obstructive pulmonary disease at women with arterial hypertension: features of the functional condition of kidneys

Cardiosomatics ◽

10.26442/cs45147 ◽

2015 ◽

Vol 6 (2) ◽

pp. 40-46

Author(s):

A. V Padyganova

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Arterial Hypertension ◽

Pulmonary Disease ◽

Functional Condition ◽

Pulmonary Diseases ◽

Chronic Obstructive ◽

Case Histories ◽

Obstructive Pulmonary Disease ◽

Gender Factor ◽

A Current

The prevalence of concomitant cardiovascular and pulmonary diseases is high. In this article features of a current of an arterial hypertension with chronic obstructive pulmonary disease taking into account a gender factor are surveyed. Results of own analysis of these case histories of patients with chronic obstructive pulmonary disease and the arterial hypertension (n=133), the level which has taped reliable rising of a cholesterin at patients at association of pathology of respiratory system and circulation organs are presented. Also in article the questions concerning features of a functional condition of kidneys at women with a joint current of chronic obstructive pulmonary disease and arterial hypertension are discussed.

Download Full-text